Financials AJJ Medtech Holdings Limited
Equities
584
SG0584008601
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.004 SGD | 0.00% | 0.00% | -42.86% |
03-13 | AJJ Medtech Holdings Limited Appoints Mr. Chua June Gay as an Executive Officer | CI |
03-06 | AJJ Medtech Completes Share Issue to Cut Debt | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 4.678 | 5.346 | 14.01 | 12.14 | 7.47 | 6.537 |
Enterprise Value (EV) 1 | 5.857 | 14.6 | 14.17 | 10.01 | 8.613 | 9.002 |
P/E ratio | -9.02 x | -5.6 x | -4.19 x | -7.16 x | -1.76 x | -2.59 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 6.13 x | 25.8 x | 19.8 x | 38.1 x | 9.59 x | 4.05 x |
EV / Revenue | 7.68 x | 70.5 x | 20.1 x | 31.4 x | 11.1 x | 5.57 x |
EV / EBITDA | -125 x | -23.9 x | -5.84 x | -2.68 x | -2.04 x | -3.79 x |
EV / FCF | -44.1 x | -175 x | -1.84 x | 3.71 x | -4.87 x | -10.9 x |
FCF Yield | -2.27% | -0.57% | -54.3% | 26.9% | -20.5% | -9.18% |
Price to Book | 0.72 x | 0.97 x | 1.96 x | 2.23 x | 6.25 x | -4.91 x |
Nbr of stocks (in thousands) | 668,267 | 668,267 | 933,802 | 933,802 | 933,802 | 933,802 |
Reference price 2 | 0.007000 | 0.008000 | 0.0150 | 0.0130 | 0.008000 | 0.007000 |
Announcement Date | 19-04-11 | 20-04-15 | 21-04-07 | 22-04-14 | 23-04-12 | 24-04-12 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 0.763 | 0.207 | 0.706 | 0.319 | 0.779 | 1.615 |
EBITDA 1 | -0.047 | -0.61 | -2.427 | -3.736 | -4.213 | -2.374 |
EBIT 1 | -0.385 | -0.949 | -2.811 | -3.919 | -4.454 | -2.553 |
Operating Margin | -50.46% | -458.45% | -398.16% | -1,228.53% | -571.76% | -158.08% |
Earnings before Tax (EBT) 1 | -0.414 | -1.057 | -2.79 | -1.737 | -4.524 | -2.563 |
Net income 1 | -0.519 | -0.955 | -2.757 | -1.696 | -4.241 | -2.527 |
Net margin | -68.02% | -461.35% | -390.51% | -531.66% | -544.42% | -156.47% |
EPS 2 | -0.000776 | -0.001429 | -0.003581 | -0.001816 | -0.004541 | -0.002706 |
Free Cash Flow 1 | -0.1328 | -0.0836 | -7.692 | 2.697 | -1.768 | -0.8265 |
FCF margin | -17.4% | -40.4% | -1,089.48% | 845.38% | -226.89% | -51.18% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 19-04-11 | 20-04-15 | 21-04-07 | 22-04-14 | 23-04-12 | 24-04-12 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 1.18 | 9.26 | 0.16 | - | 1.14 | 2.47 |
Net Cash position 1 | - | - | - | 2.13 | - | - |
Leverage (Debt/EBITDA) | -25.09 x | -15.17 x | -0.0667 x | - | -0.2713 x | -1.038 x |
Free Cash Flow 1 | -0.13 | -0.08 | -7.69 | 2.7 | -1.77 | -0.83 |
ROE (net income / shareholders' equity) | -7.65% | -15.9% | -44.2% | -27.8% | -131% | 5,684% |
ROA (Net income/ Total Assets) | -2.78% | -4.98% | -13.7% | -27.5% | -52.5% | -49.1% |
Assets 1 | 18.67 | 19.17 | 20.19 | 6.173 | 8.072 | 5.146 |
Book Value Per Share 2 | 0.0100 | 0.0100 | 0.0100 | 0.0100 | 0 | -0 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Capex | - | - | 0.41 | 0.5 | - | - |
Capex / Sales | - | - | 58.22% | 156.74% | - | - |
Announcement Date | 19-04-11 | 20-04-15 | 21-04-07 | 22-04-14 | 23-04-12 | 24-04-12 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-42.86% | 4.08M | |
-3.54% | 184B | |
-0.58% | 109B | |
-2.74% | 68.37B | |
+4.84% | 51.56B | |
+10.40% | 44.69B | |
+3.32% | 41.49B | |
+2.87% | 26.75B | |
+4.61% | 26.7B | |
+12.53% | 25.68B |
- Stock Market
- Equities
- 584 Stock
- Financials AJJ Medtech Holdings Limited